Rafael Holdings RFL
NYSE RFL
$2.02 +0.00 (+0.00%)
As of: Sep 29, 2026 · 3:58 PM EDT

Rafael Holdings (RFL) EBT Margin (2017 - 2026)

Updated

Rafael Holdings' EBT Margin came in at -1620.11% for fiscal Q3 2026 (quarter ended Apr 30, 2026), up 175.47 percentage points from -1795.58% a year earlier and up 1365.67 percentage points from the prior quarter.

Analysis

Rafael Holdings (RFL) EBT Margin (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Apr 30, 2026, Rafael Holdings reported EBT Margin of -3183.27%, up 361.54 percentage points year-over-year; for FY2025 (ended Jul 31, 2025), it came in at -3620.07%, up 6938.96 percentage points from FY2024.

  • EBT Margin carries a five-year change of -3479.21 percentage points (FY2020 to FY2025).
  • Going back by fiscal year, EBT Margin was -10559.03% in FY2024 (-7424.62 pp), -3134.41% in FY2023 (+31005.10 pp), -34139.51% in FY2022 (-31218.56 pp) and -2920.95% in FY2021 (-2780.09 pp).
  • The fiscal Q3 2026 figure represents the highest quarterly EBT Margin since fiscal Q2 2024.
  • Year-over-year, EBT Margin has increased for three consecutive quarters, with an average year-over-year change of +150.98 percentage points over the last eight quarters.
  • The fastest year-over-year change in EBT Margin over five years came in fiscal Q1 2023 (a gain of 59737.68 percentage points), and the weakest in fiscal Q1 2022 (a drop of 67024.57 percentage points).
  • Business Quant data shows RFL's EBT Margin at -2985.78% (Q2 2026), -4083.33% (Q1 2026) and -3484.57% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Rafael Holdings 102.93 Mn 108.34 Mn 163,000.00 -1,620.11%
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -1,620.11%
Jan 31, 2026 -2,985.78%
Oct 31, 2025 -4,083.33%
Jul 31, 2025 -3,484.57%
Apr 30, 2025 -1,795.58%
Jan 31, 2025 -6,892.21%
Oct 31, 2024 -7,187.50%
Jul 31, 2024 -2,994.55%
Apr 30, 2024 -19,315.48%
Jan 31, 2024 8,985.29%
Oct 31, 2023 -5,202.94%
Jul 31, 2023 2,151.47%
Apr 30, 2023 -2,477.46%
Jan 31, 2023 -4,638.57%
Oct 31, 2022 -7,431.43%
Jul 31, 2022 -6,731.88%
Apr 30, 2022 -6,553.95%
Jan 31, 2022 -2,774.32%
Oct 31, 2021 -67,169.11%
Apr 30, 2021 -276.97%
API Access

Rafael Holdings EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=RFL&period=max&api_key=YOUR_API_KEY